Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era

被引：3
|
作者：
Liang, Xiping [1 ]
Hu, Renzhi [1 ]
Li, Qiying [1 ]
Wang, Chaoyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Dept Hematol Oncol, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY | 2023年 / 122卷
关键词：
NCCN-IPI; EXPRESSION; CLASSIFICATION; BIOMARKER; SURVIVAL; ACCURATE; SUBTYPES; MARKER; DNA;
D O I：
10.1016/j.exphem.2023.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [1] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Huang, Yu-Chung
    Liu, Chun-Yu
    Lu, Hsueh-Ju
    Liu, Han-Tsung
    Hung, Man-Hsin
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1513 - 1520
  • [2] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    Kobayashi, T.
    Kuroda, J.
    Yokota, I.
    Tanba, K.
    Fujino, T.
    Kuwahara, S.
    Isa, R.
    Yamaguchi, J.
    Kawata, E.
    Akaogi, T.
    Uchiyama, H.
    Kaneko, H.
    Uoshima, N.
    Kobayashi, Y.
    Teramukai, S.
    Taniwaki, M.
    BLOOD CANCER JOURNAL, 2016, 6 : e383 - e383
  • [3] Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
    Seki, Ritsuko
    Ohshima, Koichi
    Fujisaki, Tomoaki
    Uike, Naokuni
    Kawano, Fumio
    Gondo, Hisashi
    Makino, Shigeyoshi
    Eto, Tetsuya
    Moriuchi, Yukiyoshi
    Taguchi, Fumihiro
    Kamimura, Tomohiko
    Tsuda, Hiroyuki
    Ogawa, Ryosuke
    Shimoda, Kazuya
    Yamashita, Kiyoshi
    Suzuki, Keiko
    Suzushima, Hitoshi
    Tsukazaki, Kunihiro
    Higuchi, Masakazu
    Utsunomiya, Atae
    Iwahashi, Masahiro
    Imamura, Yutaka
    Tamura, Kazuo
    Suzumiya, Junji
    Yoshida, Minoru
    Abe, Yasunobu
    Matsumoto, Tadashi
    Okamura, Takashi
    CANCER SCIENCE, 2009, 100 (10): : 1842 - 1847
  • [4] Diffuse large B-cell lymphoma - a new look and old prognostic factors
    Dobrea, Camelia
    Al Salamat, Hamed
    Lupu, Anca Roxana
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2012, 20 (04): : 307 - 315
  • [5] Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era
    Provencio, Mariano
    Martin, Paloma
    Garcia, Vanesa
    Candia, Antonio
    Sanchez, Antonio C.
    Bellas, Carmen
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2021 - 2030
  • [6] Prognostic factors for primary diffuse large B-cell lymphoma of the brain
    Zhou, Zhuoya
    Chen, Jing
    ASIAN JOURNAL OF SURGERY, 2023, 46 (10) : 4357 - 4362
  • [7] Prognostic factors in diffuse large B-cell lymphoma at diagnosis (international prognostic index excluded)
    Calvani, Julien
    Meignin, Veronique
    Vercellino, Laetitia
    Thieblemont, Catherine
    HEMATOLOGIE, 2021, 27 : 5 - 17
  • [8] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [9] Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
    Pileri, Stefano A.
    Tripodo, Claudio
    Melle, Federica
    Motta, Giovanna
    Tabanelli, Valentina
    Fiori, Stefano
    Vegliante, Maria Carmela
    Mazzara, Saveria
    Ciavarella, Sabino
    Derenzini, Enrico
    CELLS, 2021, 10 (03) : 1 - 15
  • [10] Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
    Bo Jia
    Yuankai Shi
    Mei Dong
    Fengyi Feng
    Sheng Yang
    Hua Lin
    Liqiang Zhou
    Shengyu Zhou
    Shanshan Chen
    Jianliang Yang
    Peng Liu
    Yan Qin
    Changgong Zhang
    Lin Gui
    Lin Wang
    Xue Wang
    Xiaohui He
    Chinese Journal of Cancer Research, 2014, 26 (04) : 459 - 465
12345